Zoetis Inc Expands Kalamazoo, Michigan, Manufacturing & Distribution Hub
05/11/2017
Renovations to the 524,000-square foot facility in Kalamazoo will expand production of Simparica (sarolaner) Chewables, the innovative oral flea and tick medication for dogs, which was approved by the U.S. Food and Drug Administration in February 2016. The company expects to begin renovations later this month and to complete the project by early 2019.
Zoetis will install two new production lines and related operations to manufacture oral tablet and chewable medicines for companion animals. The company expects to add up to 45 manufacturing positions in the next three years. The company currently employs approximately 300 colleagues at its manufacturing facilities in Kalamazoo and Portage, including 265 dedicated directly to manufacturing.
“Kalamazoo is home to one of the largest and most important manufacturing sites in Zoetis’ Global Manufacturing and Supply network,” said Matthew Everhart, Vice President, Pharmaceutical and Aseptic Operations, Global Manufacturing and Supply at Zoetis.
“Locating manufacturing here gives us continued access to a highly skilled and diverse workforce which is essential to managing a global animal health company. Our people provide our veterinarian and livestock farmer customers with a reliable supply of high quality medicines for their animals and are an integral part of the community here,” he added.
“We are committed to enhancing our manufacturing operations in Kalamazoo and thank the Michigan Economic Development Corporation, the cities of Kalamazoo and Portage, and Southwest Michigan First for their efforts to attract and help businesses grow in Michigan.”
The Michigan Economic Development Corporation (MEDC) awarded Zoetis a Business Development Program incentive grant.
“Today’s investment announcement by Zoetis will foster a long-term positive impact on western Michigan’s economy and bring new jobs to the area. Numerous public and private partners deserve thanks for helping make this project happen, and we are pleased to support that collaboration,” said MEDC Chief Executive Officer Steve Arwood. “Zoetis’ decision to bolster its production of medicines here demonstrates that our business climate and our state’s world-class talent make Michigan a top destination for biotech companies to locate, expand and grow new jobs.”
Project Announcements
Aster Brands Locates Headquarters In Little Traverse Township, Michigan
02/09/2025
Flash Steelworks Expands St. Clair County, Michigan, Operations
02/09/2025
Coast Packing Company Establishes Amarillo, Texas, Operations
02/09/2025
CC Patio Establishes Phoenix, Arizona, Manufacturing Operations
02/09/2025
Cold-Link Logistics Plans Lumberton, North Carolina, Warehouse Operations
02/09/2025
PBS Aerospace Plans Roswell, Georgia, Headquarters-Research Operations
02/09/2025
Most Read
-
2024's Leading Metro Locations: U.S. Cities on the Rise Amid an Economic Reshuffling
Q4 2024
-
The Workforce Factor: How States Are Competing to Build Tomorrow's Talent
Q4 2024
-
Best Practices in Incentives Procurement
Q4 2024
-
NEW NIMBYism: A Threat to The U.S. Economy
Q4 2024
-
Five Strategies to Tackle the Data Center Talent Shortage
Q4 2024
-
Microsoft-Three Mile Island Deal Could Signal Path for Nuclear Power to Strengthen Partnerships with Big Tech
Q4 2024
-
Industries Look for Employees in Nontraditional Spaces Amid Labor Shortage
Q4 2024